GSK Records $400M Legal Charge In Off-Label Probe
In a possible signal of an impending settlement, GlaxoSmithKline PLC said it would record a $400 million legal charge in the fourth quarter of 2008 related to a U.S. Department of...To view the full article, register now.
Already a subscriber? Click here to view full article